Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online October 24, 2007
Diabetes Care 31:3-8, 2008
DOI: 10.2337/dc07-0939
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-0939v1
31/1/3    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Equitani, F.
Right arrow Articles by Manco, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Equitani, F.
Right arrow Articles by Manco, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Clinical Care/Education/Nutrition/Psychosocial Research
Original Research

Bloodletting Ameliorates Insulin Sensitivity and Secretion in Parallel to Reducing Liver Iron in Carriers of HFE Gene Mutations

Francesco Equitani, MD1, Josè Manuel Fernandez-Real, MD2, Giacomo Menichella, MD1, Maurizio Koch, MD3, Menotti Calvani, MD4, Valerio Nobili, MD5, Geltrude Mingrone, MD, PHD4 and Melania Manco, MD, PHD5

1 Transfusion Medicine, SanFilippo Neri Hospital, Rome, Italy
2 Section of Diabetes, Endocrinology, and Nutrition, University Hospital, Girona, Spain
3 Liver Unit, SanFilippo Neri Hospital, Rome, Italy
4 Department of Internal Medicine, Catholic University, Rome, Italy
5 Department of Hepato-Gastroenterology and Nutrition, Bambino Gesù Hospital and Research Institute, Rome, Italy

Address correspondence and reprint requests to Melania Manco, MD, PhD, Department of Hepato-Gastroenterology and Nutrition, Bambino Gesù Hospital and Research Institute, S. Onofrio 4 square, 00165 Rome, Italy, E-mail: melaniamanco{at}tiscali.it

OBJECTIVE—To clarify the pathogenesis of diabetes associated with mutations of the hemochromatosis (HFE) gene, 17 carriers, 9 normal glucose tolerant (NGT) and 8 diabetic, were evaluated in an interventional trial.

RESEARCH DESIGN AND METHODS—At enrollment and after a 2-year bloodletting period, euglycemic-hyperinsulinemic clamp, oral glucose tolerance test (OGTT), liver histology (nonalcoholic fatty liver disease activity score [NAS]), and liver iron content (LIC) were assessed.

RESULTS—NGT subjects had significantly higher baseline insulin sensitivity (P ≤ 0.001), secretion, and insulinogenic index (calculated from the OGTT) (P ≤ 0.0001 for both) and lower LIC (P = 0.004) and NAS (P = 0.02) than diabetic patients. Baseline LIC correlated negatively with insulin secretion (NGT r0 = –0.676, P ≤ 0.0001; diabetes r0 = –0.589, P = 0.02) and insulin sensitivity (M value) (NGT r0 = –0.597, P = 0.009; diabetes r0 = –0.535, P = 0.03) and positively with NAS (diabetes r0 = 0.649, P = 0.007) and triglycerides (NGT r0 = 0.563, P = 0.015). At month 24, circulating iron was reduced by 179 ± 26% in NGT and 284 ± 54% in diabetic subjects. Insulin secretion (NGT 20 ± 4%; diabetes 33 ± 7%) and insulin sensitivity (NGT 25 ± 5%; diabetes 18 ± 3%) increased. LIC decreased in both groups (NGT 126 ± 42%; diabetes 61 ± 13%), and NAS ameliorated (NGT 65.1 ± 6.5 vs. 38.1 ± 6.83; P ≤ 0.0001; diabetes 2.1 ± 10.7 vs. 69.9 ± 10; P ≤ 0.0001).

CONCLUSIONS—Iron depletion ameliorates insulin secretion and sensitivity in NGT and diabetic carriers of HFE gene mutations. This amelioration occurs in parallel with decreased LIC and improved NAS. These results justify glucose tolerance testing and prophylactic iron depletion in asymptomatic carriers as well.

Abbreviations: ALT, alanine aminotransferase • AST, aspartate aminotransferase • FFM, free fat mass • HH, type 1 hereditary hemochromatosis • IGI, insulinogenic index • LIC, liver iron content • NAFLD, nonalcoholic fatty liver disease • NAS, nonalcoholic fatty liver disease activity score • NGT, normal glucose tolerant • NMR, nuclear magnetic resonance • OGTT, oral glucose tolerance test


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
L. Valenti, P. Dongiovanni, A. L. Fracanzani, and S. Fargion
Bloodletting Ameliorates Insulin Sensitivity and Secretion in Parallel to Reducing Liver Iron in Carriers of HFE Gene Mutations: Response to Equitani et al.
Diabetes Care, March 1, 2008; 31(3): e18 - e18.
[Full Text] [PDF]


Home page
Diabetes CareHome page
M. Manco, G. Mingrone, V. Nobili, and F. Equitani
Bloodletting Ameliorates Insulin Sensitivity and Secretion in Parallel to Reducing Liver Iron in Carriers of HFE Gene Mutations: Response to Valenti et al.
Diabetes Care, March 1, 2008; 31(3): e19 - e19.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.